The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Primary Pulmonary Hypertension: A Vascular Biology and Translational Research “Work in Progress”
Open accessAbstract
Abstract—Primary pulmonary hypertension (PPH) is a syndrome of dyspnea, chest pain, and syncope defined by increased pulmonary vascular resistance and the absence of a known cause. It also occurs in a familial form, which is linked to unidentified genes on chromosome 2. This syndrome is characterized by abnormalities of pulmonary vascular biology in each compartment of the blood vessel. The lumen has a prothrombotic diathesis, the endothelium displays an excessive production of vasoconstrictors relative to vasodilators, and the smooth muscle cells are depolarized and calcium-overloaded, which is due in part to reduced expression of voltage-gated potassium channels (Kv). This causes vasoconstriction and may promote cell proliferation. The adventitia displays excessive remodeling, which is associated with exaggerated metalloproteinase and elastase activity. Conceptually, PPH seems to require a permissive genotype, a susceptible phenotype (eg, endothelial dysfunction) and, in many cases, an exogenous trigger (eg, an anorexigen). Although there is not a generally accepted, unifying hypothesis regarding its cause, impaired function and the expression of vascular and platelet Kv channels suggest PPH may be a disease of the ion channels. Abnormal matrix metalloproteinase and elastase activity could also explain the abnormal vascular tone, platelet activation, and remodeling in PPH. Although calcium-channel blockers and prostacyclin, particularly when coadministered with warfarin, improve survival, PPH has a 5-year mortality rate of ≈50%. Pharmacological and gene therapies aimed at enhancing the activity of prostacyclin, nitric oxide synthases, and Kv channels or at inhibiting endothelin and matrix metalloproteinases are promising areas for future development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel Regulators of Bone Formation: Molecular Clones and Activities
Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., & Wang, E. A. (1988) · Science · doi:10.1126/science.3201241 · Cited by 3,903
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Self-citationNEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
Massague, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,966
Bone morphogenetic proteins: multifunctional regulators of vertebrate development.
Hogan, B. L. (1996) · Genes & Development · doi:10.1101/gad.10.13.1580 · Cited by 1,962
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Self-citationLane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., Loyd, J. E., Nichols, W. C., & Trembath, R. C. (2000) · Nature Genetics · doi:10.1038/79226 · Cited by 1,495
Giaid, A., & Saleh, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,369
Deng, Z., Morse, J. H., Slager, S. L., Cuervo, N., Moore, K. J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S. G., Barst, R. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303059 · Cited by 1,206
Christman, B. W., McPherson, C. D., Newman, J. H., King, G. A., Bernard, G. R., Groves, B. M., & Loyd, J. E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270202 · Cited by 1,187
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162
Self-citationPrimary pulmonary hypertension: natural history and the importance of thrombosis.
Fuster, V, Steele, P. M., Edwards, W. D., Gersh, B. J., McGoon, M. D., & Frye, R. L. (1984) · Circulation · doi:10.1161/01.cir.70.4.580 · Cited by 1,066
Currie, P. J., Seward, J. B., Chan, K.-L., Fyfe, D. A., Hagler, D. J., Mair, D. D., Reeder, G. S., Nishimura, R. A., & Tajik, A. J. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80477-0 · Cited by 1,002
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
Stewart, D. J., Levy, R. D., Cernacek, P., & Langleben, D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-6-464 · Cited by 980
Tuder, R. M., Groves, B. Μ., Badesch, D. B., & Voelkel, N. F. (1994) · PubMed · Cited by 891
(2006) · Encyclopedic Reference of Molecular Pharmacology · doi:10.1007/3-540-29832-0_1355 · Cited by 885
Signaling Pathways for Cardiac Hypertrophy and Failure
Hunter, J. J., & Chien, K. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411706 · Cited by 869
Heart-Lung Transplantation: Successful Therapy for Patients with Pulmonary Vascular Disease
Reitz, B. A., Wallwork, J. L., Hunt, S. A., Pennock, J. L., Billingham, M. E., Oyer, P. E., Stinson, E. B., & Shumway, N. E. (1982) · New England Journal of Medicine · doi:10.1056/nejm198203113061001 · Cited by 849
Archer, S. L., Huang, J. M., Hampl, V, Nelson, D. P., Shultz, P. J., & Weir, E. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7583 · Cited by 819
Self-citationThomson, J. R., Machado, R. D., Pauciulo, M. W., Morgan, N. V., Humbert, M., Elliott, G. C., Ward, K., Yacoub, M., Mikhail, G., Rogers, P., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.10.741 · Cited by 732
Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn
Clark, R. H., Kueser, T. J., Walker, M. W., Southgate, W. M., Huckaby, J. L., Perez, J. A., Roy, B. J., Keszler, M., & Kinsella, J. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002173420704 · Cited by 731
Sekelsky, J. J., Newfeld, S. J., Raftery, L. A., Chartoff, E. H., & Gelbart, W. M. (1995) · Genetics · doi:10.1093/genetics/139.3.1347 · Cited by 669
McLaughlin, V. V., Genthner, D. E., Panella, M. M., & Rich, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380501 · Cited by 664
Self-citationCody, R. J., Haas, G. J., Binkley, P. F., Capers, Q., & Kelley, R. (1992) · Circulation · doi:10.1161/01.cir.85.2.504 · Cited by 647
Eddahibi, S., Humbert, M. J. C., Fadel, É., Raffestin, B., Darmon, M. C., Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., & Adnot, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12805 · Cited by 579
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)89579-7 · Cited by 562
Increased plasma serotonin in primary pulmonary hypertension
Hervé, P., Launay, J.-M., Scrobohaci, M.-L., Brenot, F., Simonneau, G., Petitpretz, P., Poubeau, P., Cerrina, J., Duroux, P., & Drouet, L. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80156-9 · Cited by 560
Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin
Barst, R. J., Rubin, L. J., McGoon, M. D., Caldwell, E. J., Long, W. A., & Levy, P. S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-6-199409150-00003 · Cited by 551
BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension
Machado, R. D., Pauciulo, M. W., Thomson, J. R., Lane, K. B., Morgan, N. V., Wheeler, L., Phillips III, J. A., Newman, J., Williams, D., Galiè, N., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316947 · Cited by 535
Bellusci, S., Henderson, R., Winnier, G., Oikawa, T., & Hogan, B. L. M. (1996) · Development · doi:10.1242/dev.122.6.1693 · Cited by 483
The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels
Weir, E. K., & Archer, S. L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781921 · Cited by 465
Self-citationPietra, G. G., Edwards, W. D., Kay, J. M., Rich, S., Kernis, J., Schloo, B., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., & Detre, K. M. (1989) · Circulation · doi:10.1161/01.cir.80.5.1198 · Cited by 455
Self-citationMorrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K., & Trembath, R. C. (2001) · Circulation · doi:10.1161/hc3201.094152 · Cited by 453
Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction
Post, J. M., Hume, J. R., Archer, S. L., & Weir, E. K. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.4.c882 · Cited by 451
Self-citationHopkins, W. E., Ochoa, L. L., Richardson, G., & Trulock, E. P. (1996) · PubMed · Cited by 444
Lee, S. D., Shroyer, K. R., Markham, N. E., Cool, C. D., Voelkel, N. F., & Tuder, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1910 · Cited by 428
Yuan, J. X.-J., Aldinger, A. M., Juhaszova, M., Wang, J., Conte, J. V., Gaine, S. P., Orens, J. B., & Rubin, L. J. (1998) · Circulation · doi:10.1161/01.cir.98.14.1400 · Cited by 425
BMP Type II Receptor Is Required for Gastrulation and Early Development of Mouse Embryos
Beppu, H., Kawabata, M., Hamamoto, T., Chytil, A., Minowa, O., Noda, T., & Miyazono, K. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9670 · Cited by 421
Archer, S. L., Souil, E., Dinh-Xuan, A. T., Schremmer, B., Mercier, J. C., El Yaagoubi, A., Nguyen-Huu, L., Reeve, H. L., & Hampl, V (1998) · Journal of Clinical Investigation · doi:10.1172/jci333 · Cited by 410
Self-citationJego, P. (1996) · La Revue de Médecine Interne · doi:10.1016/0248-8663(96)83752-0 · Cited by 409
Primary pulmonary hypertension
Dresdale, D. T., Schultz, M., & Michtom, R. J. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90020-4 · Cited by 399
Rich, S., Seidlitz, M., Dodin, E., Osimani, D., Judd, D., Genthner, D., McLaughlin, V., & Francis, G. (1998) · Chest · doi:10.1378/chest.114.3.787 · Cited by 371
Self-citationVascular Matrix Metalloproteinase-2 Cleaves Big Endothelin-1 Yielding a Novel Vasoconstrictor
Fernandez-Patron, C., Radomski, M. W., & Davidge, S. T. (1999) · Circulation Research · doi:10.1161/01.res.85.10.906 · Cited by 366
Yoshibayashi, M., Nishioka, K., Nakao, K., Saito, Y., Matsumura, M., Ueda, T., Temma, S., Shirakami, G., Imura, H., & Mikawa, H. (1991) · Circulation · doi:10.1161/01.cir.84.6.2280 · Cited by 332
Nootens, M., Kaufmann, E., Rector, T., Toher, C., Judd, D., Francis, G. S., & Rich, S. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00399-1 · Cited by 317
Self-citationLong-Term Outcome after Pulmonary Thromboendarterectomy
ARCHIBALD, C. J., AUGER, W. R., FEDULLO, P. F., CHANNICK, R. N., KERR, K. M., JAMIESON, S. W., KAPELANSKI, D. P., WATT, C. N., & MOSER, K. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9808109 · Cited by 315
Hoeper, M. M., Olschewski, H., Ghofrani, H. A., Wilkens, H., Winkler, J., Borst, M. M., Niedermeyer, J., Fabel, H., & Seeger, W. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00494-5 · Cited by 313
Cool, C. D., Stewart, J. S., Werahera, P., Miller, G. J., Williams, R. L., Voelkel, N. F., & Tuder, R. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65137-1 · Cited by 309
Humbert, M., Monti, G., Fartoukh, M., Magnan, A., Brenot, F., Rain, B., Capron, F., Galanaud, P., Duroux, P., Simonneau, G., et al. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11030554 · Cited by 306
Shapiro, S. M., Oudiz, R. J., Cao, T., Romano, M. A., Beckmann, X. J., Georgiou, D., Mandayam, S., Ginzton, L. E., & Brundage, B. H. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00187-3 · Cited by 303
Cowan, K. N., Jones, P. L., & Rabinovitch, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci6539 · Cited by 302
Attenuated K+ channel gene transcription in primary pulmonary hypertension
Yuan, X.-J., Wang, J., Juhaszova, M., Gaine, S. P., & Rubin, L. J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78495-6 · Cited by 298
Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32
Nichols, W. C., Koller, D. L., Slovis, B., Foroud, T., Terry, V. H., Arnold, N. D., Siemieniak, D. R., Wheeler, L., Phillips, J. A., Newman, J. H., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-277 · Cited by 281
Patel, A. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.22.6615 · Cited by 277
ShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide
Kalman, K., Pennington, M. W., Lanigan, M. D., Nguyen, A., Rauer, H., Mahnir, V., Paschetto, K., Kem, W. R., Grissmer, S., Gutman, G. A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32697 · Cited by 256
Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension.
Loyd, J. E., Butler, M. G., Foroud, T. M., Conneally, P. M., Phillips, J. A., & Newman, J. H. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599869 · Cited by 254
Steudel, W., Ichinose, F., Huang, P. L., Hurford, W. E., Jones, R. C., Bevan, J. A., Fishman, M. C., & Zapol, W. M. (1997) · Circulation Research · doi:10.1161/01.res.81.1.34 · Cited by 251
Primary Pulmonary Hypertension Between Inflammation and Cancer
Voelkel, N. F., Cool, C., Lee, S. D., Wright, L., Geraci, M. W., & Tuder, R. M. (1998) · Chest · doi:10.1378/chest.114.3_supplement.225s · Cited by 221
Weir, E. K., Reeve, H. L., Huang, J. M. C., Michelakis, E., Nelson, D. P., Hampl, V., & Archer, S. L. (1996) · Circulation · doi:10.1161/01.cir.94.9.2216 · Cited by 218
Self-citationRegulation of sarcoplasmic reticulum gene expression during cardiac and skeletal muscle development
Arai, M., Otsu, K., MacLennan, D. H., & Periasamy, M. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.3.c614 · Cited by 218
McLaughlin, V. V., Genthner, D. E., Panella, M. M., Hess, D. M., & Rich, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-9-199905040-00014 · Cited by 216
Self-citationRothman, R. B., Ayestas, M. A., Dersch, C. M., & Baumann, M. H. (1999) · Circulation · doi:10.1161/01.cir.100.8.869 · Cited by 213
Mechanisms and Pathology of Monocrotaline Pulmonary Toxicity
Wilson, D. W., Segall, H. J., Pan, L. C., Lamé, M. W., Estep, J. E., & Morin, D. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209146311 · Cited by 209
Rich, S., & McLaughlin, V. V. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00320-4 · Cited by 205
Self-citationFatal Pulmonary Hypertension Associated with Short-Term Use of Fenfluramine and Phentermine
Mark, E. J., Patalas, E. D., Chang, H. T., Evans, R. J., & Kessler, S. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370904 · Cited by 179
Pulmonary hypertension and fenfluramine
Douglas, J. G., Munro, J. F., Kitchin, A. H., Muir, A. L., & Proudfoot, A. T. (1981) · BMJ · doi:10.1136/bmj.283.6296.881 · Cited by 175
Chronic hypoxia decreases KVchannel expression and function in pulmonary artery myocytes
Platoshyn, O., Yu, Y., Golovina, V. A., McDaniel, S. S., Krick, S., Li, L., Wang, J.-Y., Rubin, L. J., & Yuan, J. X.-J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.4.l801 · Cited by 174
Factors Influencing the Idiopathic Development of Pulmonary Hypertension in the Fawn Hooded Rat
Sato, K., Webb, S. A., Tucker, A., Rabinovitch, M., OʼBrien, R. F., McMurtry, I. F., & Stelzner, T. J. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.4_pt_1.793 · Cited by 167
High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension
Mason, N. A., Springall, D. R., Burke, M. M., Pollock, J. S., Mikhail, G., Yacoub, M. H., & Polak, J. M. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<313::aid-path93>3.0.co;2-8 · Cited by 166
Givertz, M. M., Colucci, W. S., LeJemtel, T. H., Gottlieb, S. S., Hare, J. M., Slawsky, M. T., Leier, C. V., Loh, E., Nicklas, J. M., & Lewis, B. E. (2000) · Circulation · doi:10.1161/01.cir.101.25.2922 · Cited by 161
Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension
Stelzner, T. J., OʼBrien, R. F., Yanagisawa, M., Sakurai, T., Sato, K., Webb, S., Zamora, M., McMurtry, I. F., & Fisher, J. (1992) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1992.262.5.l614 · Cited by 161
Nitric Oxide and Endothelin-1 in Pulmonary Hypertension
Giaid, A. (1998) · CHEST Journal · doi:10.1378/chest.114.3_supplement.208s · Cited by 157
The Pressure-Overloaded Right Ventricle in Pulmonary Hypertension
Bristow, M. R., Zisman, L. S., Lowes, B. D., Abraham, W. T., Badesch, D. B., Groves, B. Μ., Voelkel, N. F., Lynch, D. M. B., & Quaife, R. A. (1998) · CHEST Journal · doi:10.1378/chest.114.1_supplement.101s · Cited by 146
Endothelin-1 in the lungs of patients with pulmonary hypertension
Cacoub, P. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00189-7 · Cited by 146
Mesa, R. A., Edell, E. S., Dunn, W. F., & Edwards, W. D. (1998) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)63616-1 · Cited by 143
Hyperuricemia in Severe Pulmonary Hypertension
Voelkel, M. A., Wynne, K. M., Badesch, D. B., Groves, B. Μ., & Voelkel, N. F. (2000) · CHEST Journal · doi:10.1378/chest.117.1.19 · Cited by 138
Inhaled nitric oxide in primary pulmonary hypertension
Ricciardi, M. J., Knight, B. P., Martínez, F. J., & Rubenfire, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00361-1 · Cited by 118
Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension
Egermayer, P., Town, G. I., & Peacock, A. (1999) · Thorax · doi:10.1136/thx.54.2.161 · Cited by 116
Nitric Oxide Deficiency in Fenfluramine- and Dexfenfluramine-induced Pulmonary Hypertension
Archer, S. L., Djaballah, K., Humbert, M. J. C., Weir, Ε. K., Fartoukh, M. S., DALL'AVA-SANTUCCI, J., Mercier, J., Simonneau, G., & Dinh‐Xuan, A. T. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.4.9802113 · Cited by 112
Self-citationChen, S., Chen, Y.-F., Opgenorth, T. J., et al. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199706000-00003 · Cited by 111
Champion, H. C., Bivalacqua, T. J., D’Souza, F. M., Ortiz, L. A., Jeter, J. R., Toyoda, K., Heistad, D. D., Hyman, A. L., & Kadowitz, P. J. (1999) · Circulation Research · doi:10.1161/01.res.84.12.1422 · Cited by 105
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure
Hampl, V., Archer, S. L., Nelson, D. P., & Weir, Ε. K. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.75.4.1748 · Cited by 105
Self-citationChampion, H. C., Bivalacqua, T. J., Toyoda, Ḱ., Heistad, D. D., Hyman, A. L., & Kadowitz, P. J. (2000) · Circulation · doi:10.1161/01.cir.101.8.923 · Cited by 101
Packer, M., Medina, N., & Yushak, M. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80048-0 · Cited by 97
Saji, T., Ozawa, Y., Ishikita, T., Matsuura, H., & Matsuo, N. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)90408-7 · Cited by 96
A Placebo-Controlled Trial of Prostacyclin in Acute Respiratory Failure in COPD
Archer, S. L., Mike, D. K., Crow, J. W., Long, W. A., & Weir, Ε. K. (1996) · CHEST Journal · doi:10.1378/chest.109.3.750 · Cited by 88
Self-citationDeng, Z., Haghighi, F. G., HELLEBY, L., VANTERPOOL, K., Horn, E. M., Barst, R. J., Hodge, S. E., Morse, J. H., & Knowles, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9906051 · Cited by 87
Potassium Channels in Cardiovascular Biology
(2001) · Springer eBooks · doi:10.1007/978-1-4615-1303-2 · Cited by 71
Hp, G. (1979) · PubMed · Cited by 68
Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat
Cras, T. D. L., Kim, D.-H., Gebb, S. A., Markham, N. E., Shannon, J. M., Tuder, R. M., & Abman, S. H. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.277.4.l709 · Cited by 68
Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension
deCaestecker, M. P., & Meyrick, B. O. (2001) · Respiratory Research · doi:10.1186/rr57 · Cited by 66
Endothelin-1 and serotonin: Mediators of primary and secondary pulmonary hypertension?
MacLean, M. R. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90114-2 · Cited by 64
Urinary cGMP concentrations in severe primary pulmonary hypertension
Bogdan, M., Humbert, M., Francoual, J., et al. (1998) · Thorax · doi:10.1136/thx.53.12.1059 · Cited by 53
Pathogenesis of Inherited Forms of Dilated Cardiomyopathy
Graham, R. M., & Owens, W. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412309 · Cited by 52
Weir, Ε. K., Reeve, H. L., Johnson, G. J., Michelakis, E. D., Nelson, D. P., & Archer, S. L. (1998) · CHEST Journal · doi:10.1378/chest.114.3_supplement.200s · Cited by 50
Self-citationBertolino, F., Valentin, J., Maffre, M., Jover, B. F., Bessac, A. M., & John, G. W. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39007-5 · Cited by 45
Action of fenfluramine on voltage- gated K+ channels in human pulmonary-artery smooth-muscle cells
Wang, J., Juhaszova, M., Conte, J. V., Gaine, S., Rubin, L. J., & Yuan, J. X.-J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)60264-4 · Cited by 43
Rabinovitch, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14205 · Cited by 36
Long-Term Effects of Cicletanine on Secondary Pulmonary Hypertension
Saadjian, A., Philip‐Joet, F., Paganelli, F. F., Arnaud, A., & Lévy, S. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199803000-00006 · Cited by 35
Partial Reversal of Hypoxic Pulmonary Hypertension by Heparin
Hassoun, P. M., Thompson, B., & Hales, C. A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.1.193 · Cited by 32
Reeve, H. L., Archer, S. L., Soper, M., & Weir, Ε. K. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.277.3.l662 · Cited by 31
Self-citationReeve, H. L., Nelson, D. P., Archer, S. L., & Weir, Ε. K. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.2.l213 · Cited by 30
Self-citationMichelakis, E. D., Weir, Ε. K., Nelson, D. P., Reeve, H. L., Tolarová, S., & Archer, S. L. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35220-6 · Cited by 28
Self-citationForrest, I., Small, T., & Corris, P. A. (1999) · Clinical Science · doi:10.1042/cs19990006 · Cited by 26
Epidemics of vascular toxicity and pulmonary hypertension: what can be learned?
Egermayer, P. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00586.x · Cited by 18
Petros, A., Turner, S. C. M., & Nunn, A. J. (1995) · Journal of Pharmacy Technology · doi:10.1177/875512259501100409 · Cited by 15
Cited by
Dweik, R. A., Boggs, P. B., Erzurum, S. C., Irvin, C. G., Leigh, M. W., Lundberg, J. O., Olin, A.-C., Plummer, A. L., & Taylor, D. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.9120-11st · Cited by 2,539
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,360
Self-citationCellular and molecular pathobiology of pulmonary arterial hypertension
Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.029 · Cited by 1,576
Self-citationWriting Committee Members, McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192230 · Cited by 1,093
Self-citationPulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Metadata
- Authors
- Archer, S., & Rich, S.
- Venue
- Circulation
- Published
- 2000-11-28
- Volume
- 102
- Issue
- 22
- Pages
- 2781-2791
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2010171666
- Cited by
- 354
- References
- 108
- FWCI
- 15.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.